News
Novo Nordisk appoints Mike Doustdar as new CEO
Digest more
Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...
Also in today’s newsletter, India says it killed Kashmir terror attack perpetrators, and Novo Nordisk’s shares plunge ...
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of ...
Pharmaceutical Technology on MSN8d
Fangzhou and Novo Nordisk link on chronic disease managementFangzhou has signed a MoU with Novo Nordisk to collaborate on the management of serious chronic diseases, including obesity and diabetes.
Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback